- Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum
- Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
- Ikena Oncology to Participate in TD Cowen 44th Annual Health Care Conference
- Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer
- Ikena Oncology Outlines Key Priorities and Provides Corporate Updates
- Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results
- Ikena Oncology to Present at Multiple November 2023 Investor Conferences
- Ikena Oncology to Participate in September 2023 Investor Conferences
- Ikena Oncology Reports Second Quarter 2023 Financial Results and Corporate Update
- Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction
More ▼
Key statistics
On Thursday, Ikena Oncology Inc (IKNA:NMQ) closed at 1.31, 28.43% above the 52 week low of 1.02 set on Nov 09, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.28 |
---|---|
High | 1.36 |
Low | 1.28 |
Bid | 1.26 |
Offer | 1.36 |
Previous close | 1.31 |
Average volume | 211.39k |
---|---|
Shares outstanding | 48.26m |
Free float | 45.33m |
P/E (TTM) | -- |
Market cap | 63.22m USD |
EPS (TTM) | -1.63 USD |
Data delayed at least 15 minutes, as of Apr 25 2024 21:00 BST.
More ▼